Brian T. Powl, Chief Commercial Officer at Kura Oncology, Inc. (KURA), sold 17,782 shares at $8.94 ($159K) on 2025-09-29, disclosed to the SEC on 2025-09-29.
Open-market sale of $159k KURA by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.94 | 8,891 | $79K | 50.0% |
| 2 | $8.94 | 8,891 | $79K | 50.0% |
| Total | $8.94 avg | 17,782 | $159K | 100% |
| Filing → |
| KURA | SELL | 2026-05-20 | $3K | — | Filing → |
| KURA | SELL | 2026-01-27 | $54K | — | Filing → |
| KURA | SELL | 2025-11-14 | $199K | — | Filing → |